Skip to main content

Table 1 Subject characteristics of asthma (A) and healthy (H) subjects

From: In vivo imaging of the airway wall in asthma: fibered confocal fluorescence microscopy in relation to histology and lung function

  A H
   Total HA HNA
Subjects (n) 8 8 5 3
Male/Female (n) 2/6 4/4 2/3 2/1
Age (years) a 24 (2) 28 (10) 30 (12) 23 (2)
FEV 1 /FVC (%pred.)a,* 96 (9) 108 (7) 105 (7) 113 (4)
Post-bronchodilator FEV 1
(%pred.) a
108 (11) 115 (6) 115 (6) 114 (6)
Dose response slope (% decline FEV 1 /μmol methacholine)b,** 6.49
(3.47-31.30)
0.20
(0.04-0.30)
0.23
(0.10-0.49)
0.07
(0.03-0.23)
  1. Total = all healthy control subjects; HA = healthy, atopic; HNA = healthy, non-atopic
  2. a Mean (SD)
  3. b Median (P25-P75)
  4. * A vs. Total p = 0.012; A vs. HNA p = 0.016
  5. ** A vs. Total p = 0.001; A vs. HA p = 0.003; A vs. HNA p = 0.014